TRISALUS LIFE SCIENCES INC (TLSI) Stock Income Statement
NASDAQ:TLSI - Nasdaq - US89680M1018 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 29.43M | 18.51M | 0.00 | 0.00 | 0.00 | |||
| Cost Of Goods | 4.10M | 2.60M | N/A | N/A | N/A | |||
| Gross Profit | 25.33M | 15.91M | N/A | N/A | N/A | |||
| Operating Expenses | 61.49M | 70.38M | 2.75M | 3.04M | 110.00K | |||
| Research and Development | 17.69M | 29.84M | N/A | N/A | N/A | |||
| Selling, General, and Administrative Expenses | 43.80M | 40.55M | 2.75M | 3.04M | 110.00K | |||
| Operating Income | -36.16M | -54.48M | -2.75M | -3.04M | -110.00K | |||
| Interest Income/Expense | -2.69M | -3.94M | 3.02M | 60.00K | 0.00 | |||
| Other Income/Expense | 8.81M | -940.00K | 5.84M | 7.74M | -610.00K | |||
| Income Before Taxes | -30.04M | -59.35M | 6.11M | 4.77M | -710.00K | |||
| Income Tax | 6.00K | 9.00K | 570.00K | N/A | N/A | |||
| Net Income | -33.23M | -63.60M | 5.54M | 4.77M | -710.00K | |||
| EBITDA | -35.42M | -53.79M | N/A | N/A | N/A | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.31 | -6.77 | 0.19 | 0.15 | -0.02 | |||
| Non GAAP EPS | -1.33 | N/A | N/A | N/A | N/A | |||
| Statistics | ||||||||
| Gross Profit Margin | 86.06% | 85.93% | N/A | N/A | N/A | |||
| Profit Margin | -112.92% | -343.59% | N/A | N/A | N/A | |||
| Operating Profit Margin | -122.88% | -294.28% | N/A | N/A | N/A | |||
All data in USD